Summary

The global body composition analyzers market is anticipated to grow from USD 0.99 billion in 2026 to USD 1.39 billion by 2031, at a CAGR of 7.1% during the forecast period. Body composition analyzers are widely used by hospitals & clinics, fitness & wellness centers, academic & research centers, and home users. They are also used in monitoring and tailoring fitness programs based on individual body composition data. Emerging markets such as Asia Pacific offer lucrative market growth opportunities. Rising prevalence of obesity and metabolic disorders, growing adoption of preventive healthcare, and increasing demand for personalized nutrition and fitness programs drive the market. Furthermore, technological advancements in bioelectrical impedance analysis (BIA) and integration with digital health platforms and wearable devices enable more accurate, connected, and convenient body composition monitoring, driving the overall market. Bioimpedance analyzers segment to exhibit the highest growth rate from 2026 to 2031 Based on product, the bioimpedance analyzers segment is likely to register the highest growth rate in the body composition analyzers market during the forecast period. Major driving factors include continuous improvements in bioimpedance technology to enhance accuracy, reliability, and user-friendliness. The rising demand for non-invasive body composition assessment, growing adoption of multifrequency and segmental analysis, and expansion of fitness and wellness programs also contribute to the segmental growth. Additionally, increasing home-based health monitoring and integration with connected devices and digital health platforms drive the segment. These trends are enhancing measurement accuracy, accessibility, personalization, and real-time health tracking across clinical and consumer applications. Segmental body measurement segment captured the largest market share in 2025 Based on application, the segmental body measurement segment accounted for the largest share of the body composition analyzers market in 2025. Segmental body measurement offers more precise and accurate analysis compared with whole-body measurements, providing detailed insights into specific areas of the body. The segment is driven by growing demand for precise regional body composition assessment, particularly for monitoring fat distribution, muscle mass, and fluid balance. Increasing adoption in obesity management, sports performance, nutrition, and clinical care is expanding applications. Technological advances in multifrequency BIA, octopolar configurations, and digital analytics are improving regional measurement capabilities, while demand for personalized fitness and healthcare programs is encouraging broader adoption. Asia Pacific to be the fastest-growing regional market between 2026 and 2031 Based on region, Asia Pacific is expected to register the highest growth rate in the body composition analyzers market during the forecast period, mainly due to rapid urbanization and lifestyle changes, such as sedentary habits and poor diets. These devices help address emerging health concerns by providing detailed insights into body composition, which reflects the growing need for effective health management solutions. The regional market is driven by rising obesity and metabolic disorders, increasing health and fitness awareness, expanding healthcare infrastructure, and growing disposable incomes. Adoption is further supported by the expansion of fitness clubs, wellness programs, and preventive healthcare initiatives. Demand for affordable, portable, and connected analyzers, particularly across India, China, Japan, and Southeast Asia, is also accelerating market penetration. Technological advancements in BIA and digital health integration are broadening clinical, fitness, and home-use applications. A breakdown of the primary participants referred to for this report is provided below: ・ By Company Type: Tier 1–35%, Tier 2–40%, and Tier 3–25% ・ By Designation: Directors–25%, Managers–50%, and Others–25% ・ By Region: North America–43%, Europe–14%, Asia Pacific–26%, Latin America- 12%, and the Middle East & Africa- 5% Prominent players in the body composition analyzers market include GE HealthCare (US), OMRON Corporation (Japan), Hologic, Inc. (US), InBody Co., Ltd. (South Korea), Tanita Corporation (Japan), seca (Germany), Withings (France), SELVAS Healthcare, Inc. (South Korea), COSMED srl (Italy), and RJL Systems (US). Research Coverage This report studies the body composition analyzers market based on product, usage type, modality, application, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends. It forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions). Reasons to Buy the Report The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their market presence. This report provides insights into the following pointers: ・ Analysis of key drivers (Rising prevalence of obesity and focus on body fat and muscle mass assessment, Growing adoption of body composition analysis in weight management and preventive healthcare), restraints (Limited reimbursement for routine body composition assessment, High sensitivity of bioimpedance measurements to hydration status and measurement conditions), opportunities (Increasing establishment of fitness, wellness and sports performance centers, Mounting demand for connected and data-driven monitoring), and challenges (Lack of standardization, Competition from established clinical imaging technologies) influencing the growth of the body composition analyzers market ・ Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the market ・ Market Development: Comprehensive information about lucrative markets – the report analyzes the market across varied regions ・ Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the market ・ Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings of leading players such as Omron Corporation (Japan), Hologic Inc. (US), and GE Healthcare (US)

ページTOPに戻る

Table of Contents

1 INTRODUCTION 31
1.1 STUDY OBJECTIVES 31
1.2 MARKET DEFINITION 31
1.3 MARKET SCOPE 32
1.3.1 MARKET SEGMENTATION 32
1.3.2 INCLUSIONS & EXCLUSIONS 33
1.3.3 YEARS CONSIDERED 33
1.3.4 CURRENCY CONSIDERED 34
1.4 STAKEHOLDERS 34
1.5 SUMMARY OF CHANGES 34
2 EXECUTIVE SUMMARY 36
2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS 36
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 37
2.3 DISRUPTIVE TRENDS IN BODY COMPOSITION ANALYZERS MARKET 38
2.4 HIGH-GROWTH SEGMENTS 39
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 40
3 PREMIUM INSIGHTS 41
3.1 BODY COMPOSITION ANALYZERS MARKET OVERVIEW 41
3.2 EUROPE: BODY COMPOSITION ANALYZERS MARKET,
BY END USER AND COUNTRY (2025) 42
3.3 BODY COMPOSITION ANALYZERS MARKET: REGION (2026−2031) 43
4 MARKET OVERVIEW 44
4.1 INTRODUCTION 44
4.2 MARKET DYNAMICS 44
4.2.1 DRIVERS 45
4.2.1.1 Rising prevalence of obesity and increasing focus on body fat and muscle mass assessment 45
4.2.1.2 Growing adoption of body composition analysis in weight management and preventive healthcare 46
4.2.1.3 Growing geriatric population and rising demand for sarcopenia & muscle mass monitoring 47
4.2.2 RESTRAINTS 48
4.2.2.1 Limited reimbursement for routine body composition assessment 48
4.2.2.2 High sensitivity of bioimpedance measurements to hydration status and measurement conditions 49
4.2.3 OPPORTUNITIES 50
4.2.3.1 Increasing establishment of fitness, wellness, and sports performance centers 50
4.2.3.2 Growing demand for connected and data-driven monitoring 51
4.2.4 CHALLENGES 52
4.2.4.1 Lack of standardization across BIA devices, algorithms, and measurement protocols 52
4.2.4.2 Competition from established clinical imaging technologies such as CT and MRI 53
4.3 UNMET NEEDS AND WHITE SPACES 54
4.3.1 UNMET NEEDS IN BODY COMPOSITION ANALYZERS MARKET 54
4.3.2 WHITE SPACE OPPORTUNITIES 55
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 55
4.4.1 INTERCONNECTED MARKETS 55
4.4.2 CROSS-SECTOR OPPORTUNITIES 56
4.5 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS 56
4.5.1 STRATEGIC MOVES IN BODY COMPOSITION ANALYZERS MARKET 57
5 INDUSTRY TRENDS 58
5.1 PORTER’S FIVE FORCES ANALYSIS 58
5.1.1 THREAT FROM NEW ENTRANTS 59
5.1.2 THREAT FROM SUBSTITUTES 60
5.1.3 BARGAINING POWER OF SUPPLIERS 60
5.1.4 BARGAINING POWER OF BUYERS 60
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 60
5.2 MACROECONOMIC INDICATORS 61
5.2.1 INTRODUCTION 61
5.2.2 GDP TRENDS AND FORECAST 61
5.2.3 TRENDS IN GLOBAL HEALTHCARE INDUSTRY 62
5.2.4 TRENDS IN GLOBAL MEDICAL DEVICE INDUSTRY 62
5.3 SUPPLY CHAIN ANALYSIS 62
5.4 VALUE CHAIN ANALYSIS 64
5.5 ECOSYSTEM ANALYSIS 65
5.5.1 MANUFACTURERS 66
5.5.2 END USERS 67
5.5.3 REGULATORY BODIES 68
5.6 PRICING ANALYSIS 68
5.6.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER, 2023–2025 68
5.6.2 AVERAGE SELLING PRICE TREND, BY MODALITY, 2023–2025 71
5.6.3 AVERAGE SELLING PRICE TREND, BY REGION, 2023–2025 71
5.7 TRADE ANALYSIS 74
5.7.1 IMPORT DATA (HS CODE 901819) 74
5.7.2 EXPORT DATA (HS CODE 901819) 75
5.7.3 IMPORT DATA (HS CODE 903180) 76
5.7.4 EXPORT DATA FOR (HS CODE 903180) 76
5.8 REIMBURSEMENT SCENARIO 77
5.9 KEY CONFERENCES & EVENTS, 2026–2027 78
5.10 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 79
5.11 INVESTMENT & FUNDING SCENARIO 80
5.12 CASE STUDY ANALYSIS 81
5.13 IMPACT OF 2025 US TARIFFS—BODY COMPOSITION ANALYZERS MARKET 82
5.13.1 INTRODUCTION 82
5.13.2 KEY TARIFF RATES 83
5.13.3 PRICE IMPACT ANALYSIS 84
5.13.4 IMPACT ON COUNTRIES/REGIONS 85
5.13.5 IMPACT ON END-USE SEGMENTS 86
5.13.5.1 Hospitals & clinics 86
5.13.5.2 Fitness clubs & wellness centers 86
5.13.5.3 Academic & research centers 87
5.13.5.4 Home Users 87
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 88
6.1 TECHNOLOGY ANALYSIS 88
6.1.1 KEY EMERGING TECHNOLOGIES 88
6.1.1.1 Wearable body composition monitoring 88
6.1.1.2 AI-enabled body composition analysis and smartphone-based assessment 88
6.1.2 COMPLEMENTARY TECHNOLOGIES 89
6.1.2.1 Cloud-based body composition data platforms 89
6.1.2.2 Digital nutrition and weight-management technologies 89
6.1.3 ADJACENT TECHNOLOGIES 89
6.1.3.1 MRI and CT-based body composition analysis 89
6.1.3.2 Ultrasound body composition assessment 89
6.2 TECHNOLOGY/PRODUCT ROADMAP 90
6.2.1 NEAR-TERM (2025–2027) 90
6.2.2 MID-TERM (2028–2030) 90
6.2.3 LONG-TERM (2030+) 91
6.3 PATENT ANALYSIS 91
6.3.1 JURISDICTION AND TOP APPLICANT ANALYSIS 91
6.4 FUTURE APPLICATIONS 94
6.4.1 AI-ASSISTED PERSONALIZED BODY COMPOSITION MANAGEMENT 95
6.4.2 REMOTE AND HOME-BASED BODY COMPOSITION MONITORING 95
6.4.3 OBESITY AND WEIGHT-MANAGEMENT APPLICATIONS 95
6.4.4 SARCOPENIA AND MUSCLE-HEALTH ASSESSMENT 95
6.5 IMPACT OF AI/GEN AI ON BODY COMPOSITION ANALYZERS 95
6.5.1 INTRODUCTION 95
6.5.2 MARKET POTENTIAL OF AI IN BODY COMPOSITION ANALYZERS 96
6.5.3 AI USE CASES 96
6.5.4 KEY COMPANIES IMPLEMENTING AI 98
7 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES 99
7.1 REGULATORY LANDSCAPE 99
7.1.1 REGULATORY FRAMEWORK 99
7.1.1.1 North America 99
7.1.1.2 Europe 99
7.1.1.3 Asia Pacific 99
7.1.1.4 Latin America 100
7.1.1.5 Middle East & Africa 100
7.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 100
7.1.3 INDUSTRY STANDARDS 102
7.2 SUSTAINABILITY INITIATIVES 103
7.2.1 REDUCING MEDICAL WASTE & USE OF LOWER-IMPACT MATERIALS AND PACKAGING 103
7.2.2 WATER, ENERGY, AND RESOURCE EFFICIENCY 103
7.2.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 103
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 105
8.1 DECISION-MAKING PROCESS 105
8.2 KEY STAKEHOLDERS & BUYING CRITERIA 105
8.2.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 106
8.2.2 BUYING CRITERIA 107
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 108
8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 109
8.5 MARKET PROFITABILITY 109
9 BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT 111
9.1 INTRODUCTION 112
9.2 BIOIMPEDANCE ANALYZERS 114
9.2.1 MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS 116
9.2.1.1 Detailed body water and segmental assessment supporting demand 116
9.2.1.2 Global volume analysis of multi-frequency bioimpedance analyzers, 2024–2031 (units) 118
9.2.2 SINGLE-FREQUENCY BIOIMPEDANCE ANALYZERS 118
9.2.2.1 Cost-effective assessment expanding accessibility 118
9.2.2.2 Global volume analysis of single-frequency bioimpedance analyzers, 2024–2031 (units) 121
9.2.3 DUAL-FREQUENCY BIOIMPEDANCE ANALYZERS 121
9.2.3.1 Enhanced fluid assessment and practical measurement
supporting adoption 121
9.2.3.2 Global volume analysis of dual-frequency bioimpedance
analyzers, 2024–2031 (units) 123
9.3 DUAL-ENERGY X-RAY ABSORPTIOMETRY EQUIPMENT 123
9.3.1 COMPREHENSIVE BONE AND BODY COMPOSITION ASSESSMENT SUPPORTING ADOPTION 123
9.4 SKINFOLD CALIPERS 125
9.4.1 SIMPLE MEASUREMENT OF SUBCUTANEOUS FAT SUPPORTING
CONTINUED USE 125
9.5 AIR DISPLACEMENT PLETHYSMOGRAPHY EQUIPMENT 127
9.5.1 RAPID ASSESSMENT AND COST-EFFECTIVE TESTING SUPPORTING ADOPTION 127
9.6 HYDROSTATIC WEIGHING EQUIPMENT 128
9.6.1 ESTABLISHED BODY DENSITY METHOD SUPPORTING NICHE APPLICATIONS 128
10 BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE 130
10.1 INTRODUCTION 131
10.2 PROFESSIONAL-GRADE BODY COMPOSITION ANALYZERS 132
10.2.1 EXPANDING FITNESS AND SPECIALIZED ASSESSMENT FACILITIES SUPPORTING DEMAND 132
10.3 CONSUMER-GRADE BODY COMPOSITION ANALYZERS 133
10.3.1 ADVANCEMENTS IN CONNECTED AND HOME-BASED MONITORING SUPPORTING GROWTH 133
11 BODY COMPOSITION ANALYZERS MARKET, BY MODALITY 135
11.1 INTRODUCTION 136
11.2 PORTABLE BODY COMPOSITION ANALYZERS 137
11.2.1 MOBILITY AND WIRELESS DATA CONNECTIVITY SUPPORTING BROADER ADOPTION 137
11.3 STATIONARY/BENCHTOP BODY COMPOSITION ANALYZERS 138
11.3.1 STANDARDIZED MEASUREMENT AND PROFESSIONAL-GRADE FEATURES SUPPORTING ADOPTION 138
12 BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION 140
12.1 INTRODUCTION 141
12.2 SEGMENTAL BODY MEASUREMENT 142
12.2.1 DETAILED REGIONAL ANALYSIS SUPPORTING PERSONALIZED ASSESSMENT 142
12.3 WHOLE-BODY MEASUREMENT 144
12.3.1 COMPREHENSIVE BODY COMPOSITION ASSESSMENT SUPPORTING WIDER APPLICATION 144
13 BODY COMPOSITION ANALYZERS MARKET, BY END USER 146
13.1 INTRODUCTION 147
13.2 FITNESS CLUBS & WELLNESS CENTERS 148
13.2.1 EXPANDING FITNESS INFRASTRUCTURE SUPPORTING DEMAND 148
13.3 HOSPITALS & CLINICS 150
13.3.1 OSTEOPOROSIS ASSESSMENT AND CLINICAL BODY COMPOSITION MONITORING SUPPORTING DEMAND 150
13.4 ACADEMIC & RESEARCH CENTERS 151
13.4.1 INCREASING RESEARCH FUNDING AND TECHNOLOGY VALIDATION ACTIVITIES SUPPORTING DEMAND 151
13.5 HOME USERS 152
13.5.1 CONNECTED AND USER-FRIENDLY DEVICES SUPPORTING HOME-BASED MONITORING 152
14 BODY COMPOSITION ANALYZERS MARKET, BY REGION 154
14.1 INTRODUCTION 155
14.2 NORTH AMERICA 155
14.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 156
14.2.2 NORTH AMERICA: VOLUME ANALYSIS, 2024–2031 (UNITS) 157
14.2.3 US 160
14.2.3.1 High Obesity Prevalence and Growing Need for Direct Body Composition Assessment Driving Market Growth 160
14.2.4 CANADA 163
14.2.4.1 Increasing Adiposity and Growing Attention to Abdominal Fat Assessment Supporting Market Growth 163
14.3 EUROPE 166
14.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 166
14.3.2 EUROPE: VOLUME ANALYSIS, 2024–2031 (UNITS) 167
14.3.3 GERMANY 170
14.3.3.1 Widespread Excess Weight and Rising Demand for More Detailed Body Assessment Supporting Market Growth 170
14.3.4 FRANCE 173
14.3.4.1 Growing Clinical Use of Body Composition Assessment in Obesity Care Supporting Market Growth 173
14.3.5 UK 176
14.3.5.1 Expansion of Large-Scale Body Composition Research Supporting Demand for Advanced Assessment Technologies 176
14.3.6 ITALY 178
14.3.6.1 Growing Adoption of Body Composition Assessment in Obesity Management Supporting Market Expansion 178
14.3.7 SPAIN 181
14.3.7.1 Increasing Use of Body Composition Monitoring in Obesity and Metabolic Health Supporting Market Growth 181
14.3.8 REST OF EUROPE 184
14.4 ASIA PACIFIC 186
14.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 186
14.4.2 ASIA PACIFIC: VOLUME ANALYSIS, 2024–2031 (UNITS) 188
14.4.3 CHINA 191
14.4.3.1 Rising cases of obesity in children to propel the market 191
14.4.4 JAPAN 194
14.4.4.1 Growing Emphasis on Healthy Aging and Muscle Mass Assessment Creating Demand for Body Composition Technologies 194
14.4.5 INDIA 197
14.4.5.1 Expanding Obesity Management Initiatives and Greater Focus on Body Fat Assessment Driving Market Growth 197
14.4.6 AUSTRALIA 200
14.4.6.1 Use of body composition assessment in high-performance sports to sustain demand 200
14.4.7 SOUTH KOREA 203
14.4.7.1 Evolving Obesity Assessment Practices Driving Demand for Body Composition Technologies 203
14.4.8 REST OF ASIA PACIFIC 206
14.5 LATIN AMERICA 208
14.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 208
14.5.2 LATIN AMERICA: VOLUME ANALYSIS, 2024–2031 (UNITS) 209
14.5.3 BRAZIL 212
14.5.3.1 Strengthening Obesity Management Practices Creating Opportunities for Body Composition Assessment 212
14.5.4 MEXICO 215
14.5.4.1 Increasing Emphasis on Comprehensive Obesity Assessment Creating Opportunities for Body Composition Technologies 215
14.5.5 REST OF LATIN AMERICA 218
14.6 MIDDLE EAST & AFRICA 220
14.6.1 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK 220
14.6.2 MIDDLE EAST & AFRICA: VOLUME ANALYSIS, 2024–2031 (UNITS) 221
14.6.3 GCC COUNTRIES 224
14.6.3.1 Kingdom of Saudi Arabia 227
14.6.3.1.1 Expanding weight management programs creating opportunities for body composition assessment 227
14.6.3.2 UAE 229
14.6.3.2.1 Rising emphasis on obesity prevention and weight management to propel market 229
14.6.4 REST OF GCC COUNTRIES 232
14.6.5 REST OF MIDDLE EAST & AFRICA 234
15 COMPETITIVE LANDSCAPE 237
15.1 OVERVIEW 237
15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 237
15.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE BODY COMPOSITION ANALYZERS MARKET 238
15.3 REVENUE ANALYSIS 239
15.4 MARKET SHARE ANALYSIS 240
15.4.1 GLOBAL BODY COMPOSITION ANALYZERS MARKET SHARE ANALYSIS, 2025 240
15.4.2 US BODY COMPOSITION ANALYZERS MARKET SHARE ANALYSIS, 2025 241
15.4.3 EUROPE BODY COMPOSITION ANALYZERS MARKET SHARE ANALYSIS, 2025 243
15.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 245
15.5.1 STARS 245
15.5.2 EMERGING LEADERS 245
15.5.3 PERVASIVE PLAYERS 245
15.5.4 PARTICIPANTS 245
15.6 COMPANY FOOTPRINT 247
15.6.1 COMPANY FOOTPRINT: KEY PLAYERS, 2025 247
15.6.1.1 Company footprint 247
15.6.1.2 Region footprint 248
15.6.1.3 Product footprint 249
15.6.1.4 Modality footprint 250
15.6.1.5 Usage type footprint 251
15.6.1.6 Application footprint 252
15.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 253
15.7.1 PROGRESSIVE COMPANIES 253
15.7.2 RESPONSIVE COMPANIES 253
15.7.3 DYNAMIC COMPANIES 253
15.7.4 STARTING BLOCKS 253
15.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 255
15.7.5.1 Detailed list of key startups/SMEs 255
15.7.5.2 Competitive benchmarking of key startups/SMEs 256
15.8 COMPANY VALUATION & FINANCIAL METRICS 257
15.8.1 FINANCIAL METRICS 257
15.8.2 COMPANY VALUATION 257
15.9 BRAND/PRODUCT COMPARISON 258
15.10 COMPETITIVE SCENARIO 259
15.10.1 PRODUCT LAUNCHES & APPROVALS 259
15.10.2 DEALS 260
15.10.3 EXPANSIONS 261
15.10.4 OTHER DEVELOPMENTS 261
16 COMPANY PROFILES 262
16.1 KEY PLAYERS 262
16.1.1 GE HEALTHCARE 262
16.1.1.1 Business overview 262
16.1.1.2 Products offered 263
16.1.1.3 Recent developments 264
16.1.1.3.1 Deals 264
16.1.1.4 MnM view 264
16.1.1.4.1 Key strengths/Right to win 264
16.1.1.4.2 Strategic choices 265
16.1.1.4.3 Weaknesses & competitive threats 265
16.1.2 OMRON CORPORATION 266
16.1.2.1 Business overview 266
16.1.2.2 Products offered 267
16.1.2.3 Recent developments 268
16.1.2.3.1 Deals 268
16.1.2.3.2 Expansions 269
16.1.2.4 MnM view 269
16.1.2.4.1 Key strengths/Right to win 269
16.1.2.4.2 Strategic choices 269
16.1.2.4.3 Weaknesses & competitive threats 269
16.1.3 HOLOGIC, INC. 270
16.1.3.1 Business overview 270
16.1.3.2 Products offered 271
16.1.3.3 Recent developments 272
16.1.3.3.1 Deals 272
16.1.3.4 MnM view 272
16.1.3.4.1 Key strengths/Right to win 272
16.1.3.4.2 Strategic choices 272
16.1.3.4.3 Weaknesses & competitive threats 272
16.1.4 INBODY CO., LTD. 273
16.1.4.1 Business overview 273
16.1.4.2 Products offered 274
16.1.4.3 Recent developments 275
16.1.4.3.1 Product launches & approvals 275
16.1.4.3.2 Expansions 276
16.1.4.4 MnM view 276
16.1.4.4.1 Key strengths/Right to win 276
16.1.4.4.2 Strategic choices 276
16.1.4.4.3 Weaknesses & competitive threats 276
16.1.5 SELVAS HEALTHCARE, INC. 277
16.1.5.1 Business overview 277
16.1.5.2 Products offered 278
16.1.5.3 Recent developments 279
16.1.5.3.1 Other developments 279
16.1.6 IMPEDIMED LIMITED 280
16.1.6.1 Business overview 280
16.1.6.2 Products offered 281
16.1.7 DMS IMAGING 282
16.1.7.1 Business overview 282
16.1.7.2 Products offered 283
16.1.7.3 Recent developments 284
16.1.7.3.1 Product launches & approvals 284
16.1.7.3.2 Deals 284
16.1.8 A&D COMPANY, LIMITED 285
16.1.8.1 Business overview 285
16.1.8.2 Products offered 286
16.1.8.3 Recent developments 287
16.1.8.3.1 Deals 287
16.1.9 XIAOMI CORPORATION 288
16.1.9.1 Business overview 288
16.1.9.2 Products offered 289
16.1.9.3 Recent developments 290
16.1.9.3.1 Product launches & approvals 290
16.1.10 TANITA CORPORATION 291
16.1.10.1 Business overview 291
16.1.10.2 Products offered 291
16.1.10.3 Recent developments 293
16.1.10.3.1 Product launches & approvals 293
16.1.10.3.2 Deals 293
16.1.11 SECA 294
16.1.11.1 Business overview 294
16.1.11.2 Products offered 294
16.1.11.3 Recent developments 295
16.1.11.3.1 Product launches 295
16.1.11.3.2 Deals 295
16.1.12 WITHINGS 296
16.1.12.1 Business overview 296
16.1.12.2 Products offered 296
16.1.12.3 Recent developments 297
16.1.12.3.1 Product & services launches 297
16.1.12.3.2 Deals 297
16.1.13 COSMED S.R.L. 299
16.1.13.1 Business overview 299
16.1.13.2 Products offered 299
16.1.13.3 Recent developments 300
16.1.13.3.1 Deals 300
16.1.14 RJL SYSTEMS 301
16.1.14.1 Business overview 301
16.1.14.2 Products offered 301
16.1.15 CHARDER ELECTRONIC CO., LTD. 302
16.1.15.1 Business overview 302
16.1.15.2 Products offered 302
16.1.15.3 Recent developments 303
16.1.15.3.1 Other developments 303
16.1.16 BODYSTAT LIMITED 304
16.1.16.1 Business overview 304
16.1.16.2 Products offered 304
16.2 OTHER PLAYERS 305
16.2.1 MALTRON INTERNATIONAL LTD. 305
16.2.2 AKERN S.R.L. 306
16.2.3 BIOTEKNA 307
16.2.4 BIODYNAMICS CORPORATION 307
16.2.5 MICROLIFE CORPORATION 308
16.2.6 NUMED S.A.R.L. 309
16.2.7 TONGYONG TIZHI HEALTH TECHNOLOGY CO., LTD. 310
16.2.8 FOOK TIN TECHNOLOGIES LTD. 311
16.2.9 OSTEOSYS CORP. 312
16.2.10 EXERTECH 312
16.2.11 SHANGHAI GOLDENWELL MEDICAL TECHNOLOGY CO., LTD. 313
17 RESEARCH METHODOLOGY 314
17.1 RESEARCH DATA 314
17.1.1 SECONDARY DATA 315
17.1.1.1 Key secondary sources 316
17.1.2 PRIMARY DATA 316
17.1.2.1 Primary sources 317
17.1.2.2 Key data from primary sources 318
17.1.2.3 Key industry insights 318
17.1.2.4 Breakdown of primaries 319
17.2 MARKET SIZE ESTIMATION 320
17.2.1 APPROACH 1: COMPANY REVENUE ANALYSIS APPROACH 322
17.2.2 APPROACH 2: CUSTOMER-BASED MARKET ESTIMATION 323
17.2.3 APPROACH 3: TOP-DOWN APPROACH 323
17.2.4 APPROACH 4: BOTTOM-UP APPROACH 324
17.2.5 APPROACH 5: PRIMARY INTERVIEWS 324
17.2.6 APPROACH 6: DEMAND-SIDE APPROACH 325
17.2.7 APPROACH 7: VOLUME DATA ANALYSIS 326
17.3 DATA TRIANGULATION AND MARKET BREAKDOWN 329
17.4 MARKET SHARE ASSESSMENT 330
17.5 RESEARCH ASSUMPTIONS 330
17.5.1 STUDY ASSUMPTIONS 330
17.5.2 GROWTH RATE ASSUMPTIONS 330
17.6 RISK ASSESSMENT 331
17.6.1 RESEARCH LIMITATIONS 331
18 APPENDIX 332
18.1 DISCUSSION GUIDE 332
18.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 337
18.3 CUSTOMIZATION OPTIONS 339
18.3.1 PRODUCT ANALYSIS 339
18.3.2 COMPANY INFORMATION 339
18.3.3 GEOGRAPHIC ANALYSIS 339
18.4 RELATED REPORTS 339
18.5 AUTHOR DETAILS 340

ページTOPに戻る

List of Tables/Graphs

TABLE 1 STANDARD CURRENCY CONVERSION RATES 34.
TABLE 2 BODY COMPOSITION ANALYZERS MARKET: PORTER’S FIVE FORCES ANALYSIS 58.
TABLE 3 GDP CHANGE, BY KEY COUNTRY, 2021–2030 (USD BILLION) 61.
TABLE 4 LIST OF KEY BODY COMPOSITION ANALYZERS MANUFACTURERS 67.
TABLE 5 LIST OF KEY END USERS 67.
TABLE 6 LIST OF KEY REGULATORY BODIES 68.
TABLE 7 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYER, 2023–2025 (USD) 68.
TABLE 8 AVERAGE SELLING PRICE TREND, BY MODALITY, 2023–2025 (USD) 71.
TABLE 9 AVERAGE SELLING PRICE TREND, BY REGION, 2023–2025 (USD) 71.
TABLE 10 IMPORT DATA FOR HS CODE 901819-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND) 74.
TABLE 11 EXPORT DATA FOR HS CODE 901819-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND) 75.
TABLE 12 IMPORT DATA FOR HS CODE 903180-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND) 76.
TABLE 13 EXPORT DATA FOR HS CODE 903180-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND) 76.
TABLE 14 BODY COMPOSITION ANALYZERS MARKET: MAJOR CONFERENCES & EVENTS, 2026–2027 78.
TABLE 15 SECA MBCA – BODY COMPOSITION MONITORING DURING INJURY REHABILITATION 81.
TABLE 16 EVOLT 360 – GNC TULSA HILLS NUTRITION RETAIL APPLICATION 81.
TABLE 17 CHARDER ELECTRONIC – TAIWAN TECH FITNESS ASSESSMENT PROGRAM 82.
TABLE 18 RECIPROCAL TARIFF RATES ADJUSTED BY US, 2025 83.
TABLE 19 KEY PRODUCT-RELATED TARIFFS 84.
TABLE 20 NORTH AMERICA: IMPACT OF US TARIFF ON CANADA 85.
TABLE 21 ASIA PACIFIC: IMPACT OF US TARIFF ON CHINA, JAPAN, AND INDIA 85.
TABLE 22 EUROPE: IMPACT OF US TARIFF ON GERMANY AND UK 85.
TABLE 23 LATIN AMERICA: IMPACT OF US TARIFF ON MEXICO 86.
TABLE 24 BODY COMPOSITION ANALYZERS MARKET: KEY PATENTS, 2015–2026 93.
TABLE 25 COMPANIES IMPLEMENTING AI 98.
TABLE 26 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 100.
TABLE 27 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 101.
TABLE 28 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 101.
TABLE 29 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 102.
TABLE 30 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 102.
TABLE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BODY COMPOSITION ANALYZERS 107.
TABLE 32 KEY BUYING CRITERIA FOR BODY COMPOSITION ANALYZERS, BY END USER 108.
TABLE 33 BODY COMPOSITION ANALYZERS MARKET: ADOPTION BARRIERS & INTERNAL CHALLENGES 108.
TABLE 34 BODY COMPOSITION ANALYZERS MARKET: UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 109.
TABLE 35 BODY COMPOSITION ANALYZERS MARKET: KEY PROFITABILITY DRIVERS 110.
TABLE 36 BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 112.
TABLE 37 PRODUCT: BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 113.
TABLE 38 BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 114.
TABLE 39 BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 115.
TABLE 40 KEY PLAYERS PROVIDING MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS 116.
TABLE 41 MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 117.
TABLE 42 MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2024–2031 (UNITS) 118.
TABLE 43 KEY PLAYERS PROVIDING SINGLE-FREQUENCY BIOIMPEDANCE ANALYZERS 119.
TABLE 44 SINGLE-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 120.
TABLE 45 SINGLE-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2024–2031 (UNITS) 121.
TABLE 46 KEY PLAYERS PROVIDING DUAL-FREQUENCY BIOIMPEDANCE ANALYZERS 122.
TABLE 47 DUAL-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 122.
TABLE 48 DUAL-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2024–2031 (UNITS) 123.
TABLE 49 KEY PLAYERS PROVIDING DUAL-ENERGY X-RAY ABSORPTIOMETRY 124.
TABLE 50 DUAL-ENERGY X-RAY ABSORPTIOMETRY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 124.
TABLE 51 KEY PLAYERS PROVIDING SKINFOLD CALIPERS 125.
TABLE 52 SKINFOLD CALIPERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 126.
TABLE 53 KEY PLAYERS PROVIDING AIR DISPLACEMENT PLETHYSMOGRAPHY 127.
TABLE 54 AIR DISPLACEMENT PLETHYSMOGRAPHY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 127.
TABLE 55 KEY PLAYERS PROVIDING HYDROSTATIC WEIGHING EQUIPMENT 128.
TABLE 56 HYDROSTATIC WEIGHING EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 129.
TABLE 57 BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 131.
TABLE 58 USAGE TYPE: BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 131.
TABLE 59 PROFESSIONAL-GRADE BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 133.
TABLE 60 CONSUMER-GRADE BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 134.
TABLE 61 BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 136.
TABLE 62 MODALITY: BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 136.
TABLE 63 PORTABLE BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 137.
TABLE 64 STATIONARY/BENCHTOP BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 139.
TABLE 65 BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 141.
TABLE 66 APPLICATION: BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 141.
TABLE 67 BODY COMPOSITION ANALYZERS MARKET FOR SEGMENTAL BODY MEASUREMENT, BY COUNTRY, 2024–2031 (USD MILLION) 143.
TABLE 68 BODY COMPOSITION ANALYZERS MARKET FOR WHOLE-BODY MEASUREMENT, BY COUNTRY, 2024–2031 (USD MILLION) 144.
TABLE 69 BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 147.
TABLE 70 END USER: BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 147.
TABLE 71 BODY COMPOSITION ANALYZERS MARKET FOR FITNESS CLUBS & WELLNESS CENTERS, BY COUNTRY, 2024–2031 (USD MILLION) 149.
TABLE 72 BODY COMPOSITION ANALYZERS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2024–2031 (USD MILLION) 150.
TABLE 73 BODY COMPOSITION ANALYZERS MARKET FOR ACADEMIC & RESEARCH CENTERS, BY COUNTRY, 2024–2031 (USD MILLION) 152.
TABLE 74 BODY COMPOSITION ANALYZERS MARKET FOR HOME USERS, BY COUNTRY, 2024–2031 (USD MILLION) 153.
TABLE 75 BODY COMPOSITION ANALYZERS MARKET, BY REGION, 2024–2031 (USD MILLION) 155.
TABLE 76 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2024–2031 (UNITS) 157.
TABLE 77 NORTH AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 158.
TABLE 78 NORTH AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 158.
TABLE 79 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 158.
TABLE 80 NORTH AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 159.
TABLE 81 NORTH AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 159.
TABLE 82 NORTH AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 159.
TABLE 83 NORTH AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 160.
TABLE 84 US: MACROECONOMIC INDICATORS 161.
TABLE 85 US: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 161.
TABLE 86 US: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 161.
TABLE 87 US: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 162.
TABLE 88 US: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 162.
TABLE 89 US: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 162.
TABLE 90 US: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 163.
TABLE 91 CANADA: MACROECONOMIC INDICATORS 163.
TABLE 92 CANADA: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 164.
TABLE 93 CANADA: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 164.
TABLE 94 CANADA: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 164.
TABLE 95 CANADA: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 165.
TABLE 96 CANADA: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 165.
TABLE 97 CANADA: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 165.
TABLE 98 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2024–2031 (UNITS) 167.
TABLE 99 EUROPE: BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 167.
TABLE 100 EUROPE: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 168.
TABLE 101 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 168.
TABLE 102 EUROPE: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 168.
TABLE 103 EUROPE: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 169.
TABLE 104 EUROPE: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 169.
TABLE 105 EUROPE: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 169.
TABLE 106 GERMANY: MACROECONOMIC INDICATORS 170.
TABLE 107 GERMANY: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 171.
TABLE 108 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 171.
TABLE 109 GERMANY: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 171.
TABLE 110 GERMANY: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 172.
TABLE 111 GERMANY: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 172.
TABLE 112 GERMANY: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 172.
TABLE 113 FRANCE: MACROECONOMIC INDICATORS 173.
TABLE 114 FRANCE: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 174.
TABLE 115 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 174.
TABLE 116 FRANCE: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 174.
TABLE 117 FRANCE: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 175.
TABLE 118 FRANCE: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 175.
TABLE 119 FRANCE: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 175.
TABLE 120 UK: MACROECONOMIC INDICATORS 176.
TABLE 121 UK: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 176.
TABLE 122 UK: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 177.
TABLE 123 UK: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 177.
TABLE 124 UK: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 177.
TABLE 125 UK: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 178.
TABLE 126 UK: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 178.
TABLE 127 ITALY: MACROECONOMIC INDICATORS 179.
TABLE 128 ITALY: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 179.
TABLE 129 ITALY: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 179.
TABLE 130 ITALY: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 180.
TABLE 131 ITALY: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 180.
TABLE 132 ITALY: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 180.
TABLE 133 ITALY: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 181.
TABLE 134 SPAIN: MACROECONOMIC INDICATORS 181.
TABLE 135 SPAIN: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 182.
TABLE 136 SPAIN: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 182.
TABLE 137 SPAIN: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 182.
TABLE 138 SPAIN: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 183.
TABLE 139 SPAIN: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 183.
TABLE 140 SPAIN: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 183.
TABLE 141 REST OF EUROPE: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 184.
TABLE 142 REST OF EUROPE: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 184.
TABLE 143 REST OF EUROPE: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 185.
TABLE 144 REST OF EUROPE: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 185.
TABLE 145 REST OF EUROPE: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 185.
TABLE 146 REST OF EUROPE: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 186.
TABLE 147 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2024–2031 (UNITS) 188.
TABLE 148 ASIA PACIFIC: BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 188.
TABLE 149 ASIA PACIFIC: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 189.
TABLE 150 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 189.
TABLE 151 ASIA PACIFIC: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 189.
TABLE 152 ASIA PACIFIC: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 190.
TABLE 153 ASIA PACIFIC: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 190.
TABLE 154 ASIA PACIFIC: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 190.
TABLE 155 CHINA: MACROECONOMIC INDICATORS 191.
TABLE 156 CHINA: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 192.
TABLE 157 CHINA: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 192.
TABLE 158 CHINA: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 192.
TABLE 159 CHINA: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 193.
TABLE 160 CHINA: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 193.
TABLE 161 CHINA: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 193.
TABLE 162 JAPAN: MACROECONOMIC INDICATORS 194.
TABLE 163 JAPAN: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 195.
TABLE 164 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 195.
TABLE 165 JAPAN: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 195.
TABLE 166 JAPAN: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 196.
TABLE 167 JAPAN: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 196.
TABLE 168 JAPAN: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 196.
TABLE 169 INDIA: MACROECONOMIC INDICATORS 197.
TABLE 170 INDIA: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 198.
TABLE 171 INDIA: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 198.
TABLE 172 INDIA: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 198.
TABLE 173 INDIA: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 199.
TABLE 174 INDIA: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 199.
TABLE 175 INDIA: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 199.
TABLE 176 AUSTRALIA: MACROECONOMIC INDICATORS 200.
TABLE 177 AUSTRALIA: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 201.
TABLE 178 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 201.
TABLE 179 AUSTRALIA: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 201.
TABLE 180 AUSTRALIA: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 202.
TABLE 181 AUSTRALIA: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 202.
TABLE 182 AUSTRALIA: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 202.
TABLE 183 SOUTH KOREA: MACROECONOMIC INDICATORS 203.
TABLE 184 SOUTH KOREA: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 204.
TABLE 185 SOUTH KOREA: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 204.
TABLE 186 SOUTH KOREA: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 204.
TABLE 187 SOUTH KOREA: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 205.
TABLE 188 SOUTH KOREA: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 205.
TABLE 189 SOUTH KOREA: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 205.
TABLE 190 REST OF ASIA PACIFIC: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 206.
TABLE 191 REST OF ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 206.
TABLE 192 REST OF ASIA PACIFIC: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 207.
TABLE 193 REST OF ASIA PACIFIC: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 207.
TABLE 194 REST OF ASIA PACIFIC: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 207.
TABLE 195 REST OF ASIA PACIFIC: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 208.
TABLE 196 LATIN AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2024–2031 (UNITS) 209.
TABLE 197 LATIN AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 209.
TABLE 198 LATIN AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 210.
TABLE 199 LATIN AMERICA: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 210.
TABLE 200 LATIN AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 210.
TABLE 201 LATIN AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 211.
TABLE 202 LATIN AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 211.
TABLE 203 LATIN AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 211.
TABLE 204 BRAZIL: MACROECONOMIC INDICATORS 212.
TABLE 205 BRAZIL: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 213.
TABLE 206 BRAZIL: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 213.
TABLE 207 BRAZIL: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 213.
TABLE 208 BRAZIL: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 214.
TABLE 209 BRAZIL: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 214.
TABLE 210 BRAZIL: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 214.
TABLE 211 MEXICO: MACROECONOMIC INDICATORS 215.
TABLE 212 MEXICO: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 216.
TABLE 213 MEXICO: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 216.
TABLE 214 MEXICO: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 216.
TABLE 215 MEXICO: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 217.
TABLE 216 MEXICO: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 217.
TABLE 217 MEXICO: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 217.
TABLE 218 REST OF LATIN AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 218.
TABLE 219 REST OF LATIN AMERICA: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 218.
TABLE 220 REST OF LATIN AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 219.
TABLE 221 REST OF LATIN AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 219.
TABLE 222 REST OF LATIN AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 219.
TABLE 223 REST OF LATIN AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 220.
TABLE 224 MIDDLE EAST & AFRICA: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2024–2031 (UNITS) 221.
TABLE 225 MIDDLE EAST & AFRICA: BODY COMPOSITION ANALYZERS MARKET, BY REGION, 2024–2031 (USD MILLION) 221.
TABLE 226 MIDDLE EAST & AFRICA: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 222.
TABLE 227 MIDDLE EAST & AFRICA: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 222.
TABLE 228 MIDDLE EAST & AFRICA: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 222.
TABLE 229 MIDDLE EAST & AFRICA: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 223.
TABLE 230 MIDDLE EAST & AFRICA: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 223.
TABLE 231 MIDDLE EAST & AFRICA: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 223.
TABLE 232 GCC COUNTRIES: BODY COMPOSITION ANALYZERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 224.
TABLE 233 GCC COUNTRIES: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 225.
TABLE 234 GCC COUNTRIES: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 225.
TABLE 235 GCC COUNTRIES: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 225.
TABLE 236 GCC COUNTRIES: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 226.
TABLE 237 GCC COUNTRIES: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 226.
TABLE 238 GCC COUNTRIES: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 226.
TABLE 239 KINGDOM OF SAUDI ARABIA: MACROECONOMIC INDICATORS 227.
TABLE 240 KINGDOM OF SAUDI ARABIA: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 227.
TABLE 241 KINGDOM OF SAUDI ARABIA: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 228.
TABLE 242 KINGDOM OF SAUDI ARABIA: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 228.
TABLE 243 KINGDOM OF SAUDI ARABIA: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 228.
TABLE 244 KINGDOM OF SAUDI ARABIA: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 229.
TABLE 245 KINGDOM OF SAUDI ARABIA: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 229.
TABLE 246 UAE: MACROECONOMIC INDICATORS 230.
TABLE 247 UAE: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 230.
TABLE 248 UAE: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 230.
TABLE 249 UAE: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 231.
TABLE 250 UAE: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 231.
TABLE 251 UAE: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 231.
TABLE 252 UAE: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 232.
TABLE 253 REST OF GCC COUNTRIES: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 232.
TABLE 254 REST OF GCC COUNTRIES: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 233.
TABLE 255 REST OF GCC COUNTRIES: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 233.
TABLE 256 REST OF GCC COUNTRIES: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 233.
TABLE 257 REST OF GCC COUNTRIES: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 234.
TABLE 258 REST OF GCC COUNTRIES: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 234.
TABLE 259 REST OF MIDDLE EAST & AFRICA: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 235.
TABLE 260 REST OF MIDDLE EAST & AFRICA: BIOIMPEDANCE ANALYZERS MARKET, 2024–2031 (USD MILLION) 235.
TABLE 261 REST OF MIDDLE EAST & AFRICA: BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 235.
TABLE 262 REST OF MIDDLE EAST & AFRICA: BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024–2031 (USD MILLION) 236.
TABLE 263 REST OF MIDDLE EAST & AFRICA: BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 236.
TABLE 264 REST OF MIDDLE EAST & AFRICA: BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 236.
TABLE 265 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES, JANUARY 2023–JULY 2026 238.
TABLE 266 BODY COMPOSITION ANALYZERS MARKET: DEGREE OF COMPETITION 241.
TABLE 267 US BODY COMPOSITION ANALYZERS MARKET: DEGREE OF COMPETITION 242.
TABLE 268 EUROPE BODY COMPOSITION ANALYZERS MARKET: DEGREE OF COMPETITION 244.
TABLE 269 BODY COMPOSITION ANALYZERS MARKET: REGION FOOTPRINT 248.
TABLE 270 BODY COMPOSITION ANALYZERS MARKET: PRODUCT FOOTPRINT 249.
TABLE 271 BODY COMPOSITION ANALYZERS MARKET: MODALITY FOOTPRINT 250.
TABLE 272 BODY COMPOSITION ANALYZERS MARKET: USAGE TYPE FOOTPRINT 251.
TABLE 273 BODY COMPOSITION ANALYZERS MARKET: APPLICATION FOOTPRINT 252.
TABLE 274 BODY COMPOSITION ANALYZERS MARKET: DETAILED LIST OF KEY START-UPS/SMES 255.
TABLE 275 BODY COMPOSITION ANALYZERS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 256.
TABLE 276 BODY COMPOSITION ANALYZERS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JULY 2026 259.
TABLE 277 BODY COMPOSITION ANALYZERS MARKET: DEALS, JANUARY 2023– JULY 2026 260.
TABLE 278 BODY COMPOSITION ANALYZERS MARKET: EXPANSIONS, JANUARY 2023–JULY 2026 261.
TABLE 279 BODY COMPOSITION ANALYZERS MARKET: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026 261.
TABLE 280 GE HEALTHCARE: COMPANY OVERVIEW 262.
TABLE 281 GE HEALTHCARE: PRODUCTS OFFERED 263.
TABLE 282 GE HEALTHCARE: DEALS, JANUARY 2023–JULY 2026 264.
TABLE 283 OMRON CORPORATION: COMPANY OVERVIEW 266.
TABLE 284 OMRON CORPORATION: PRODUCTS OFFERED 267.
TABLE 285 OMRON CORPORATION: DEALS, JANUARY 2023–JULY 2026 268.
TABLE 286 OMRON CORPORATION: EXPANSIONS, JANUARY 2023–JULY 2026 269.
TABLE 287 HOLOGIC, INC.: COMPANY OVERVIEW 270.
TABLE 288 HOLOGIC, INC.: PRODUCTS OFFERED 271.
TABLE 289 HOLOGIC, INC.: DEALS, JANUARY 2023–JULY 2026 272.
TABLE 290 INBODY CO., LTD.: COMPANY OVERVIEW 273.
TABLE 291 INBODY CO., LTD.: PRODUCTS OFFERED 274.
TABLE 292 INBODY CO., LTD.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JULY 2026 275.
TABLE 293 INBODY CO., LTD.: EXPANSIONS, JANUARY 2023–JULY 2026 276.
TABLE 294 SELVAS HEALTHCARE, INC.: COMPANY OVERVIEW 277.
TABLE 295 SELVAS HEALTHCARE, INC.: PRODUCTS OFFERED 278.
TABLE 296 SELVAS HEALTHCARE, INC: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026 279.
TABLE 297 IMPEDIMED LIMITED: COMPANY OVERVIEW 280.
TABLE 298 IMPEDIMED LIMITED: PRODUCTS OFFERED 281.
TABLE 299 DMS IMAGING: COMPANY OVERVIEW 282.
TABLE 300 DMS IMAGING: PRODUCTS OFFERED 283.
TABLE 301 DMS IMAGING: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JULY 2026 284.
TABLE 302 DMS IMAGING: DEALS, JANUARY 2023–JULY 2026 284.
TABLE 303 A&D COMPANY, LIMITED: COMPANY OVERVIEW 285.
TABLE 304 A&D COMPANY, LIMITED: PRODUCTS OFFERED 286.
TABLE 305 A&D COMPANY, LIMITED: DEALS, JANUARY 2023–JULY 2026 287.
TABLE 306 XIAOMI CORPORATION: COMPANY OVERVIEW 288.
TABLE 307 XIAOMI CORPORATION: PRODUCTS OFFERED 289.
TABLE 308 XIAOMI CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JULY 2026 290.
TABLE 309 TANITA CORPORATION: COMPANY OVERVIEW 291.
TABLE 310 TANITA CORPORATION: PRODUCTS 291.
TABLE 311 TANITA CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JULY 2026 293.
TABLE 312 TANITA CORPORATION: DEALS, JANUARY 2023–JULY 2026 293.
TABLE 313 SECA: COMPANY OVERVIEW 294.
TABLE 314 SECA: PRODUCTS OFFERED 294.
TABLE 315 SECA: PRODUCT LAUNCHES, JANUARY 2023–JULY 2026 295.
TABLE 316 SECA: DEALS, JANUARY 2023–JULY 2026 295.
TABLE 317 WITHINGS: COMPANY OVERVIEW 296.
TABLE 318 WITHINGS: PRODUCTS OFFERED 296.
TABLE 319 WITHINGS: PRODUCT AND SERVICES LAUNCHES, JANUARY 2023–JULY 2026 297.
TABLE 320 WITHINGS: DEALS, JANUARY 2023–JULY 2026 297.
TABLE 321 COSMED S.R.L.: COMPANY OVERVIEW 299.
TABLE 322 COSMED S.R.L.: PRODUCTS OFFERED 299.
TABLE 323 COSMED S.R.L.: DEALS, JANUARY 2023–JULY 2026 300.
TABLE 324 RJL SYSTEMS: COMPANY OVERVIEW 301.
TABLE 325 RJL SYSTEMS: PRODUCTS OFFERED 301.
TABLE 326 CHARDER ELECTRONIC CO., LTD.: COMPANY OVERVIEW 302.
TABLE 327 CHARDER ELECTRONIC CO., LTD.: PRODUCTS OFFERED 302.
TABLE 328 CHARDER ELECTRONIC CO., LTD.: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026 303.
TABLE 329 BODYSTAT LIMITED: COMPANY OVERVIEW 304.
TABLE 330 BODYSTAT LIMITED: PRODUCTS OFFERED 304.
TABLE 331 MALTRON INTERNATIONAL LTD.: COMPANY OVERVIEW 305.
TABLE 332 AKERN S.R.L.: COMPANY OVERVIEW 306.
TABLE 333 BIOTEKNA: COMPANY OVERVIEW 307.
TABLE 334 BIODYNAMICS CORPORATION: COMPANY OVERVIEW 307.
TABLE 335 MICROLIFE CORPORATION: COMPANY OVERVIEW 308.
TABLE 336 NUMED S.A.R.L.: COMPANY OVERVIEW 309.
TABLE 337 TONGYONG TIZHI HEALTH TECHNOLOGY CO., LTD.: COMPANY OVERVIEW 310.
TABLE 338 FOOK TIN TECHNOLOGIES LTD.: COMPANY OVERVIEW 311.
TABLE 339 OSTEOSYS CORP.: COMPANY OVERVIEW 312.
TABLE 340 EXERTECH: COMPANY OVERVIEW 312.
TABLE 341 SHANGHAI GOLDENWELL MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW 313.
FIGURE 1 MARKET SCENARIO 36.
FIGURE 2 GLOBAL BODY COMPOSITION ANALYZERS MARKET, 2024–2031 37.
FIGURE 3 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN BODY COMPOSITION ANALYZERS MARKET, 2023–2025 38.
FIGURE 4 DISRUPTIONS INFLUENCING GROWTH OF BODY COMPOSITION ANALYZERS MARKET 38.
FIGURE 5 HIGH-GROWTH SEGMENTS IN BODY COMPOSITION ANALYZERS MARKET, 2026–2031 39.
FIGURE 6 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 40.
FIGURE 7 MARKET TRENDS SIGNAL STRONG FUTURE FOR PORTABLE, CONSUMER-GRADE, AND ADVANCED BODY COMPOSITION ASSESSMENT 41.
FIGURE 8 HOSPITALS & CLINICS DOMINATED MARKET IN 2025 42.
FIGURE 9 CHINA TO REGISTER HIGHEST GROWTH RATE TILL 2031 43.
FIGURE 10 BODY COMPOSITION ANALYZERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 44.
FIGURE 11 2030 PROJECTIONS: MEN VS. WOMEN, BY BMI CATEGORY 46.
FIGURE 12 BODY COMPOSITION ANALYZERS MARKET: PORTER’S FIVE FORCES ANALYSIS 59.
FIGURE 13 BODY COMPOSITION ANALYZERS MARKET: SUPPLY CHAIN ANALYSIS 63.
FIGURE 14 BODY COMPOSITION ANALYZERS MARKET: VALUE CHAIN ANALYSIS 64.
FIGURE 15 BODY COMPOSITION ANALYZERS MARKET ECOSYSTEM 66.
FIGURE 16 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2025 (USD) 70.
FIGURE 17 AVERAGE SELLING PRICE TREND, BY MODALITY, 2025 (USD) 71.
FIGURE 18 AVERAGE SELLING PRICE TREND, BY REGION, 2025 (USD) 73.
FIGURE 19 REVENUE SHIFT AND NEW REVENUE POCKETS FOR BODY COMPOSITION ANALYZERS DEVICES MARKET 79.
FIGURE 20 INVESTMENT & FUNDING SCENARIO 80.
FIGURE 21 TOP APPLICANTS/OWNERS (COMPANIES/INSTITUTIONS) FOR BODY COMPOSITION ANALYZERS PATENTS, JANUARY 2015–JUNE 2026 92.
FIGURE 22 BODY COMPOSITION ANALYZERS MARKET: AI USE CASES 97.
FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BODY COMPOSITION ANALYZERS 106.
FIGURE 24 KEY BUYING CRITERIA FOR BODY COMPOSITION ANALYZERS, BY END USER 107.
FIGURE 25 NORTH AMERICA: BODY COMPOSITION ANALYZERS MARKET SNAPSHOT 157.
FIGURE 26 ASIA PACIFIC: BODY COMPOSITION ANALYZERS MARKET SNAPSHOT 187.
FIGURE 27 REVENUE ANALYSIS OF KEY PLAYERS IN BODY COMPOSITION ANALYZERS MARKET (2023−2025) 239.
FIGURE 28 GLOBAL BODY COMPOSITION ANALYZERS MARKET SHARE, 2025 240.
FIGURE 29 US BODY COMPOSITION ANALYZERS MARKET SHARE, 2025 242.
FIGURE 30 EUROPE BODY COMPOSITION ANALYZERS MARKET SHARE, 2025 243.
FIGURE 31 BODY COMPOSITION ANALYZERS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 246.
FIGURE 32 BODY COMPOSITION ANALYZERS MARKET: COMPANY FOOTPRINT 247.
FIGURE 33 BODY COMPOSITION ANALYZERS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 254.
FIGURE 34 EV/EBITDA OF KEY VENDORS 257.
FIGURE 35 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 257.
FIGURE 36 BODY COMPOSITION ANALYZERS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 258.
FIGURE 37 GE HEALTHCARE: COMPANY SNAPSHOT (2025) 263.
FIGURE 38 OMRON CORPORATION: COMPANY SNAPSHOT (2025) 267.
FIGURE 39 HOLOGIC, INC.: COMPANY SNAPSHOT (2025) 271.
FIGURE 40 INBODY CO., LTD.: COMPANY SNAPSHOT (2025) 274.
FIGURE 41 SELVAS HEALTHCARE, INC.: COMPANY SNAPSHOT (2025) 278.
FIGURE 42 IMPEDIMED LIMITED: COMPANY SNAPSHOT (2025) 281.
FIGURE 43 DMS IMAGING: COMPANY SNAPSHOT (2025) 283.
FIGURE 44 A&D COMPANY, LIMITED: COMPANY SNAPSHOT (2025) 286.
FIGURE 45 XIAOMI CORPORATION: COMPANY SNAPSHOT (2025) 289.
FIGURE 46 BODY COMPOSITION ANALYZERS MARKET: RESEARCH DESIGN 314.
FIGURE 47 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 319.
FIGURE